Progranulin as a potential therapeutic agent for neurodegeneration

Degenerative brain diseases, such as Alzheimer’s disease and Parkinson’s disease remain incurable despite intense research over decades. Progranulin, a protein that was identified and characterized in our laboratories and it has been shown to inhibit the development of Parkinson’s-like and Alzheimer’s-like symptoms in experimental models in mice by the partner organization Neurodyn. We believe that […]

Read More